IM Cannabis Corp. (IMCC)
About IM Cannabis Corp.
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority revenue is generated from Germany, and also has its presence in Israel.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Market cap
- $1.7M
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $1.7M
- Shares outstanding
- 14.2M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Feb 13, 1997
IM Cannabis Corp. (IMCC) Stock Price
- Trading 97% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review IM Cannabis Corp..
Write a review
News about IM Cannabis Corp.
News & sentiment via Polygon.io
IM Cannabis Corp.: frequently asked questions
Is IM Cannabis Corp. an American company?
IM Cannabis Corp. is a US-based company, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Is IM Cannabis Corp. publicly traded?
Yes — IM Cannabis Corp. is a publicly traded company. Its stock trades under the ticker symbol IMCC on the NASDAQ.
What does IM Cannabis Corp. do?
IM Cannabis Corp. is an American Pharmaceuticals company in the Health & Beauty sector.
